KRAS and familial pancreatic carcinoma: With regard to PDAC, other signaling pathways such as Kras/Mek/Erk or src may also play a critical role in the proliferation and growth of pancreatic cancer cells, providing a partial explanation for the modest effects of RICTOR inhibition [32, 33].